Frankfurt - Delayed Quote EUR
SELLAS Life Sciences Group, Inc. (RXK3.F)
1.1760
+0.0960
+(8.89%)
At close: April 23 at 3:28:04 PM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 120.83k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| VARIAN JOHN W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 10, 2025 |
| VAN NOSTRAND ROBERT L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 10, 2025 |
| SCHEINBERG DAVID A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 10, 2025 |
| WASMAN JANE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 10, 2025 |
| CICIC DRAGAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 10, 2025 |
| BURNS JOHN THOMAS Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 10, 2025 |
| STERGIOU ANGELOS M Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 10, 2025 |
| KALIN KATHERINE BACH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 10, 2025 |
| VARIAN JOHN W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
| VAN NOSTRAND ROBERT L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
| SCHEINBERG DAVID A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
| WOOD BARBARA A General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
| WASMAN JANE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
| BURNS JOHN THOMAS Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
| STERGIOU ANGELOS M Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
| FRANCOMANO ROBERT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
| KALIN KATHERINE BACH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
Related Tickers
1OT.F Ovid Therapeutics Inc.
0.1960
-5.77%
AXD2.F Heron Therapeutics, Inc.
1.8750
+13.36%
HTD.SG Corcept Therapeutics Inc
61.76
+11.12%
1VT.MU Viking Therapeutics Inc
22.37
+7.65%
EXOZ eXoZymes, Inc.
13.53
+14.76%
AVBP ArriVent BioPharma, Inc.
21.08
+3.94%
BVNRY Bavarian Nordic A/S
7.36
0.00%
RAPP Rapport Therapeutics, Inc.
11.38
-1.47%
GYRE Gyre Therapeutics, Inc.
9.19
+6.37%
BCAX Bicara Therapeutics Inc.
15.51
+12.23%